iTeos Therapeutics, Inc. - stock earnings

ITOS Quarterly earnings

DateEarningsRevenue
2023Q4 -30.6 million USD ? USD
2023Q3 -32.2 million USD ? USD
2023Q2 -34.3 million USD ? USD
2023Q1 -15.6 million USD 12.6 million USD
2022Q4 20.5 million USD 53.9 million USD
2022Q3 991000 USD 19.5 million USD
2022Q2 5.6 million USD 41.7 million USD
2022Q1 69.6 million USD 152.5 million USD
2021Q4 184.9 million USD 240.5 million USD
2021Q3 69.6 million USD 104.3 million USD
2021Q2 -26.5 million USD ? USD
2021Q1 -13.5 million USD ? USD
2020Q4 -14.9 million USD ? USD
2020Q3 -10.7 million USD ? USD
2020Q2 -7.2 million USD ? USD
2020Q1 -5.2 million USD ? USD
2019Q4 -5.4 million USD ? USD
2019Q3 -6.9 million USD ? USD
2019Q2 -5.8 million USD ? USD
2019Q1 -4.4 million USD ? USD

ITOS Yearly earnings

DateEarningsRevenue
2023 -112.6 million USD 12.6 million USD
2022 96.7 million USD 267.6 million USD
2021 214.5 million USD 344.8 million USD
2020 -38.0 million USD ? USD
2019 -22.5 million USD ? USD
2018 -18.1 million USD ? USD

ITOS

Price: $11.66

52 week price:
8.20
18.24

Earnings Per Share: -3.15 USD

P/E Ratio: -5.75

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 231111

Market Capitalization: 397.9 million

Links: